News

Bayer Group

Bayer plans continued growth in Japan

The Bayer Group plans to expand its business in Japan – despite the difficult conditions following the earthquake and tsunami disaster – and continue to grow sales in the coming years.
» more

E.U. registration for Xarelto recommended

Bayer HealthCare

E.U. registration for Xarelto recommended
The European Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approving Xarelto™ (active ingredient: rivaroxaban) in two new indications.
» more
New growth strategy for CropScience

Bayer CropScience

New growth strategy for CropScience
Bayer CropScience is committed to focusing on four key objectives: rejuvenating its core Crop Protection business.
» more
Research center for the factory of the future

Bayer Technology Services

Research center for the factory of the future
The factory of the future will combine flexible and efficient production concepts that conserve resources.
» more
Last updated: October 27, 2011

http://www.stockholders-newsletter-q3-2011.bayer.com/en/news.aspx

Copyright © Bayer AG

Print page

Search

Download Center

Publications

Special Interest